Welch Statement on President Trump's Prescription Drug Plan
Rep. Peter Welch (D-Vt.) issued the following statement in response to President Trump’s prescription drug plan:
“Today, President Trump finally stepped up to the plate to deliver on his campaign promise to bring relief to consumers hit with skyrocketing prescription drug prices. Instead, he swung and he missed. Big Pharma wins. Consumers lose. In place of the bold action he repeatedly promised voters during his campaign, this plan nibbles around the edges of cutting drug prices and fixing a broken drug market. Had he followed through on his campaign promise to negotiate lower Medicare drug prices and import safe drugs from Canada, shock waves would have reverberated through Big Pharma. Instead, if you listen carefully, you can almost hear the champagne popping in the corporate boardrooms of drug companies across the country.”
Rep. Welch is a senior member on the House Energy & Commerce Committee and co-chair of the House Affordable Prescription Drug Task Force. He is the lead House sponsor of legislation to mandate Medicare price negotiation and author of legislation to allow for the importation of safe prescription drugs from Canada.